{"id":"W2984471036","doi":"10.1093/ibd/izz267","title":"Cost-effectiveness and Clinical Outcomes of Early Anti–Tumor Necrosis Factor–α Intervention in Pediatric Crohn’s Disease","year":2019,"lang":"en","type":"article","venue":"Inflammatory Bowel Diseases","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Canadian Institutes of Health Research; Hospital for Sick Children; University of Toronto; Ontario Ministry of Health and Long-Term Care; Canadian Federation of University Women; Crohn's and Colitis Foundation; Crohn's and Colitis Foundation of America","keywords":"Medicine; Infliximab; Adalimumab; Incremental cost-effectiveness ratio; Cost effectiveness; Observational study; Intervention (counseling); Crohn's disease; Pediatrics; Disease; Internal medicine; Cost-effectiveness analysis","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003654976,0.0006234696,0.0007790338,0.0006422891,0.000179866,0.0009860299,0.0007207999,0.0007908458,0.001695224],"category_scores_gemma":[0.01245552,0.0003853725,0.00196432,0.0005595917,0.0004614229,0.0007706772,0.000726971,0.001009201,0.00007289735],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003531485,"about_ca_system_score_gemma":0.00192953,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01149137,"about_ca_topic_score_gemma":0.006772394,"domain_scores_codex":[0.9980078,0.00136421,0.00008662938,0.0001747333,0.0001246821,0.0002419929],"domain_scores_gemma":[0.9933576,0.005072064,0.0009817971,0.0001291021,0.0001687355,0.0002906291],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","study_design_scores_codex":[0.009785974,0.001122571,0.2338933,0.0003534458,0.002311982,0.000323836,0.00008281987,0.7291995,0.000468218,0.002788911,0.0005696973,0.01909986],"study_design_scores_gemma":[0.001766486,0.006370717,0.1402953,0.0002615825,0.002450667,0.0004560523,0.00031504,0.8415815,0.0009609423,0.00459972,0.0008655416,0.00007640079],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9954364,0.001024505,0.001805992,0.0004945397,0.00001421144,0.00006018356,0.0005537407,0.00001095238,0.0005993195],"genre_scores_gemma":[0.9989254,0.0002000826,0.0005002835,0.00003051377,0.000004208991,0.00002918321,0.0002417184,0.00000149466,0.00006712647],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01149137,"threshold_uncertainty_score":0.02562284,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01631575870214123,"score_gpt":0.3022082401927084,"score_spread":0.2858924814905672,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}